Kiniksa Pharmaceuticals InternationalvsUnitedHealth

KNSA and UNH stock compared: price, dividend, valuation and results, from SEC filings.

KNSA

Kiniksa Pharmaceuticals International, plc

$93.53

Value $6.9B

-1.59%
KNSA's page

UNH

UnitedHealth Group Incorporated

$330.48

Value $300B

-5.55%
UNH's page

Kiniksa Pharmaceuticals International (KNSA) has a market value of $6.9B and UnitedHealth (UNH) $300B. Over the last year, with dividends, KNSA moved +126.6% and UNH +8.2%. The P/E is 63.3 for KNSA and 18.9 for UNH. Dividend yield: KNSA none, UNH 2.74%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    KNSA$6.9B

    UNH$300B

    UNH is 43 times KNSA

  • Revenue, 12 months

    KNSA$946M

    UNH$450B

    UNH is 475 times KNSA

  • Net income, 12 months

    KNSA$110M

    UNH$15.9B

    UNH is 145 times KNSA

  • Operating margin

    KNSA13.8%

    UNH5.3%

    8.5 points apart

  • ROIC

    KNSA15.9%

    UNH11.3%

    4.6 points apart

  • P/E

    KNSA63.3

    UNH18.9

    KNSA is 3.4 times UNH

  • Dividend yield

    KNSA0.0%

    UNH2.7%

    2.7 points apart

  • 5-year return

    KNSA+640.6%

    UNH-19.5%

    660.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

KNSA+640.6%

UNH-19.5%

25050075020222023202420252026
Returns by period
PeriodKNSAWith dividendsUNHWith dividends
1 year since November 18, 2025+126.6%Price +126.6%+8.2%Price +5.4%
3 years since November 17, 2023+495.4%+81.2% a yearPrice +495.4%-34.4%-13.1% a yearPrice -38.4%
5 years since November 18, 2021+640.6%+49.3% a yearPrice +640.6%-19.5%-4.2% a yearPrice -26.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

KNSAKiniksa Pharmaceuticals InternationalUNHUnitedHealth

Valuation

KNSAUNH
Valuation
Price$93.53$330.48
Market value$6.9B$300B
Enterprise value (EV)$6.4B$346B
P/E63.318.9
P/E, 5-year median55.025.0
P/B9.82.9
EV/EBIT48.814.5
Free cash flow yield2.8%7.6%

Results and growth

KNSAUNH
Results and growth
Revenue, 12 months$946M$450B
Net income, 12 months$110M$15.9B
Free cash flow, 12 months$197M$22.8B
Earnings per share, 12 months$1.31$17.52
Revenue growth, year on year60.1%11.8%
Revenue growth a year, past+104.8%over 4 years+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

KNSAUNH
Margins and returns on capital
Gross margin90.2%88.3%
Operating margin13.8%5.3%
Net margin11.6%3.5%
ROIC15.9%11.3%
ROE17.8%15.5%

Balance sheet

KNSAUNH
Balance sheet
Cash$569M$28.5B
Total debt$7.9M$74.3B
Net debt / EBITDA-4.31.6
Interest cover–6.2×

Dividends and buybacks

KNSAUNH
Dividends and buybacks
Dividend yield–2.7%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield–1.8%
Shareholder yield–4.6%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: KNSA or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Kiniksa Pharmaceuticals International or UnitedHealth?

By market value, UnitedHealth ($300B) is about 43.2 times Kiniksa Pharmaceuticals International ($6.9B), at today's prices.

How did KNSA and UNH stock do over the last 5 years?

Since November 18, 2021, KNSA's price moved +640.6% and UNH's -26.5%. With dividends: KNSA +640.6% (+49.3% a year), UNH -19.5% (-4.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, KNSA or UNH?

The dividend yield at today's price is none for Kiniksa Pharmaceuticals International and 2.74% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

What is the P/E of KNSA and UNH?

At today's price, the P/E is 63.3 for KNSA and 18.9 for UNH. The median of the last five years was 55.0 and 25.0, which shows where each stands against its own past.

Which has the higher profit margins, Kiniksa Pharmaceuticals International or UnitedHealth?

Over the last twelve months, the net margin was 11.6% for Kiniksa Pharmaceuticals International and 3.5% for UnitedHealth, and the operating margin 13.8% and 5.3%. Revenue was $946M and $450B.

Which is the better investment, Kiniksa Pharmaceuticals International or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.